Redactionele standaarden

Peptips publishes educational content about GLP-1 medications. The reader trust we need to earn is different from other health-adjacent sites, so our rules are stricter.

We are not a clinic

Nothing on this site is medical advice. We describe what studies, FDA labels, manufacturer documents, and peer-reviewed papers have published. We do not diagnose, treat, cure, or prevent any disease or condition. Always consult your healthcare provider.

Sourcing

Every factual claim about a specific drug, dose, or side effect is cited to an FDA-approved prescribing information document, a peer-reviewed trial, a manufacturer public technical document, or a regulatory or government document. For any significant health claim, we prefer two independent sources. When evidence is mixed, we say so.

Generic and brand names together

We always use the generic name alongside the brand name. Semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound), always both.

No telehealth recommendations

We describe the telehealth landscape neutrally when relevant. We do not recommend specific telehealth providers. We will never link a reader to a telehealth clinic for commercial purposes.

Corrections

When we are wrong, we want to know. We correct the text, add a dated correction note at the bottom of the post, and do not silently edit. Email corrections to hello@peptips.com.

Conflicts of interest

Peptips does not accept payment from drug manufacturers or from telehealth clinics in exchange for editorial coverage. When we link to a supplement brand we may earn an affiliate commission, and we disclose it on every page where it applies.

AI and our editorial process

We use AI tools in parts of our workflow. Every post is reviewed, fact-checked, and edited by a human before publication.

Images and privacy

We do not publish before/after photos, weight-loss numbers, or body-focused imagery.